m+Medelevator.RU
← Поиск публикаций
Biotechnology and bioengineering · 2026

GlycoMAC: A Multiscale Metabolic-Glycosylation Framework for Predicting Glycosylation Across Conditions in Mammalian Cell Cultures.

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Zeng Yuming, Harcum Sarah W, Pei Jinxiang, Xie Wei

Аннотация

Antibody productivity and glycosylation quality in CHO cell cultures emerge from a dynamically evolving metabolic environment, yet existing models often work in isolation or at a single scale. Here, we present a multiscale mechanistic framework linking molecular, cellular, and macroscopic scales to predict how inputs shape bioprocess trajectories. The framework combines a single-cell kinetic model of metabolism and glycosylation with a stochastic population model that captures environment-dependent transitions among growth, production, and decline states. To characterize metabolic adaptation, we introduce the cumulative variation in oxygen uptake rate, a trajectory-based biomarker that quantifies the total metabolic adjustment experienced during culture. Unlike population-averaged approaches, the model propagates cell-resolved metabolic states-including ammonia-regulated Golgi pH, nucleotide sugar availability, manganese cofactors, and synthesis rates-into glycan processing. The framework was evaluated using CHO-K1 fed-batch cultures producing VRC01 IgG1 under targeted ammonia stress, matched control conditions, and a pyramid-feeding strategy with tighter control. It accurately reproduced trajectories of cell growth, metabolites, productivity, and harvest glycosylation, including increased G0F abundance and reduced galactosylation under ammonia stress. By mechanistically linking process conditions to cell-state dynamics and glycosylation outcomes, the framework provides a unified foundation for digital bioprocessing, predictive biomanufacturing, and advanced process control.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты